MedTrace Logo

A Study to Assess the Gut Health Effects of Heat-killed Post-biotics in Overweight and Obese Adults

NCT05820737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2025-06-25

No results posted yet for this study

Summary

The present study is a randomized, double-blind (Double dummy), placebo-controlled, parallel-group study to assess the gut health effects of heat-killed post biotics in overweight and obese individuals

Conditions

  • Gastrointestinal Dysfunction

Interventions

DIETARY_SUPPLEMENT

EF2001

One capsule to be consumed once a day

DIETARY_SUPPLEMENT

beLP1

One capsule to be consumed once a day

DIETARY_SUPPLEMENT

Placebo

One capsule to be consumed once a day

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-14
Primary Completion
2025-03-24
Completion
2025-03-24

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820737 on ClinicalTrials.gov